These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33438526)

  • 1. Oncogenic potential of ATAD2 in stomach cancer and insights into the protein-protein interactions at its AAA + ATPase domain and bromodomain.
    Nayak A; Kumar S; Singh SP; Bhattacharyya A; Dixit A; Roychowdhury A
    J Biomol Struct Dyn; 2022 Aug; 40(12):5606-5622. PubMed ID: 33438526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain.
    Gay JC; Eckenroth BE; Evans CM; Langini C; Carlson S; Lloyd JT; Caflisch A; Glass KC
    Proteins; 2019 Feb; 87(2):157-167. PubMed ID: 30520161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF1α-dependent upregulation of ATAD2 promotes proliferation and migration of stomach cancer cells in response to hypoxia.
    Nayak A; Roy AD; Rout N; Singh SP; Bhattacharyya A; Roychowdhury A
    Biochem Biophys Res Commun; 2020 Mar; 523(4):916-923. PubMed ID: 31959473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain.
    Evans CM; Phillips M; Malone KL; Tonelli M; Cornilescu G; Cornilescu C; Holton SJ; Gorjánácz M; Wang L; Carlson S; Gay JC; Nix JC; Demeler B; Markley JL; Glass KC
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach.
    Miller DC; Martin MP; Adhikari S; Brennan A; Endicott JA; Golding BT; Hardcastle IR; Heptinstall A; Hobson S; Jennings C; Molyneux L; Ng Y; Wedge SR; Noble MEM; Cano C
    Org Biomol Chem; 2018 Mar; 16(11):1843-1850. PubMed ID: 29469144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging oncogene ATAD2: Signaling cascades and therapeutic initiatives.
    Nayak A; Dutta M; Roychowdhury A
    Life Sci; 2021 Jul; 276():119322. PubMed ID: 33711386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes.
    Langini C; Caflisch A; Vitalis A
    J Biol Chem; 2017 Oct; 292(40):16734-16745. PubMed ID: 28798233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Combinatorial Histone Modifications on Acetyllysine Recognition by the ATAD2 and ATAD2B Bromodomains.
    Phillips M; Malone KL; Boyle BW; Montgomery C; Kressy IA; Joseph FM; Bright KM; Boyson SP; Chang S; Nix JC; Young NL; Jeffers V; Frietze S; Glass KC
    J Med Chem; 2024 May; 67(10):8186-8200. PubMed ID: 38733345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target.
    Fu J; Zhang J; Chen X; Liu Z; Yang X; He Z; Hao Y; Liu B; Yao D
    Theranostics; 2023; 13(2):787-809. PubMed ID: 36632213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Promoting ATAD2 and Its Preclinical Challenges.
    Liu H; Wen Q; Yan S; Zeng W; Zou Y; Liu Q; Zhang G; Zou J; Zou X
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008934
    [No Abstract]   [Full Text] [Related]  

  • 11. ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation.
    Liu Q; Liu H; Li L; Dong X; Ru X; Fan X; Wen T; Liu J
    Int J Oncol; 2020 Jan; 56(1):219-231. PubMed ID: 31746426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells.
    Yao D; You J; Yang X; Zhang J; Yao X
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2242601. PubMed ID: 37533352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant genome reprogramming by ATAD2.
    Boussouar F; Jamshidikia M; Morozumi Y; Rousseaux S; Khochbin S
    Biochim Biophys Acta; 2013 Oct; 1829(10):1010-4. PubMed ID: 23831842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the human ATAD2 AAA+ histone chaperone reveals mechanism of regulation and inter-subunit communication.
    Cho C; Ganser C; Uchihashi T; Kato K; Song JJ
    Commun Biol; 2023 Sep; 6(1):993. PubMed ID: 37770645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma.
    Meng X; Wang L; Zhu B; Zhang J; Guo S; Li Q; Zhang T; Zheng Z; Wu G; Zhao Y
    Biomed Res Int; 2020; 2020():8657468. PubMed ID: 32462022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication.
    Koo SJ; Fernández-Montalván AE; Badock V; Ott CJ; Holton SJ; von Ahsen O; Toedling J; Vittori S; Bradner JE; Gorjánácz M
    Oncotarget; 2016 Oct; 7(43):70323-70335. PubMed ID: 27612420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma.
    Ekin U; Yuzugullu H; Ozen C; Korhan P; Bagirsakci E; Yilmaz F; Yuzugullu OG; Uzuner H; Alotaibi H; Kirmizibayrak PB; Atabey N; Karakülah G; Ozturk M
    J Gastrointest Cancer; 2021 Dec; 52(4):1356-1369. PubMed ID: 34738187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE.
    Guruvaiah P; Chava S; Sun CW; Singh N; Penn CA; Gupta R
    Cell Death Dis; 2023 Jul; 14(7):456. PubMed ID: 37479754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2.
    Poncet-Montange G; Zhan Y; Bardenhagen JP; Petrocchi A; Leo E; Shi X; Lee GR; Leonard PG; Geck Do MK; Cardozo MG; Andersen JN; Palmer WS; Jones P; Ladbury JE
    Biochem J; 2015 Mar; 466(2):337-46. PubMed ID: 25486442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based screening of the bromodomain of ATAD2.
    Harner MJ; Chauder BA; Phan J; Fesik SW
    J Med Chem; 2014 Nov; 57(22):9687-92. PubMed ID: 25314628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.